why is tirzepatide no longer available FDA says years-long shortage resolved, will give limited leeway to compounders Why Is Tirzepatide Not Working

3.Marso SP, et al

Tirzepatide (Mounjaro) Tirzepatide is noteworthy for its ability to target both GLP-1 and GIP receptors, a mechanism that can be particularly helpful for PCOS patients struggling with obesity and insulin resistance

Ask patient to talk back or write back what was just taught

The current improved techniques allows for much better results than what was possible several years ago

FDA-approved uses Wegovy is FDA-approved for chronic weight management in patients with obesity (body mass index 30 kg/m or greater) and overweight (body mass index 27 kg/m or greater) with at least one weight-related condition such as high blood pressure (hypertension), type 2 diabetes, high cholesterol levels, and heart disease, when used as an adjunct to a healthy lifestyle, reduced-calorie diet, and exercise